Fibroblast-specific deletion of interleukin-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction.
Bageghni SA, Hemmings KE, Yuldasheva NY, Maqbool A, Gamboa-Esteves FO, Humphreys NE, Jackson MS, Denton CP, Francis S, Porter KE, Ainscough JF, Pinteaux E, Drinkhill MJ, Turner NA.
Bageghni SA, et al. Among authors: turner na.
JCI Insight. 2019 Aug 8;5(17):e125074. doi: 10.1172/jci.insight.125074.
JCI Insight. 2019.
PMID: 31393855
Free PMC article.